ung Cancer Genomic Screening Project for Individualized Medicine in Japan (LC-SCRUM-Japan): Prospective analyses of clinicopathological and molecular characteristics in squamous cell lung cancer harboring FGFR alternation (LC-SCRUM-Japan-Sq)

Not Applicable

Recruiting

• Conditions: Squamous cell lung cancer

• Registration Number: JPRN-UMIN000016607
• Lead Sponsor: ational Cancer Center Hospital East

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-02-23
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To clarify the clinicopathological and molecular feature in squamous cell lung cancer harboring FGFR gene alterations

Secondary Outcome Measures

Name	Time	Method
To evaluate the frequencies and characteristics of any cancer-related gene alterations in squamous cell lung cancer using OCP(Cancer Panel)